HALEY BLOOM: Open Payments
NPI 1629708052 · STANTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 43 payments from 8 companies in 2025. Trend: 2023 $294 · 2024 $325 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $186 |
| GlaxoSmithKline, LLC. | 8 | $161 |
| ABBVIE INC. | 3 | $77 |
| Novo Nordisk Inc | 2 | $57 |
| Lundbeck LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: CAPLYTA, TRELEGY ELLIPTA, JARDIANCE, UBRELVY, Wegovy, Ozempic, VRAYLAR, MOUNJARO.
Industry payments across KY — which companies pay providers there.
